FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1584411000001101: Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24779701000001112 Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
24779801000001115 Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Is a Terbinafine 250mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Is pack of Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) false Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has active ingredient Terbinafine hydrochloride false Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has active ingredient Skin agent false Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has AMP Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Terbinafine true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has specific active ingredient Terbinafine hydrochloride true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd) 14 tablet Has basis of strength substance Terbinafine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start